4-(3-nitro-1H-pyrazol-1-yl)butanenitrile, 95.0%, 1g

(S)-4-Hydroxy-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-dioxide, 95.0%, 10g

4-(Hydroxymethyl)phenylacetic acid, 99.0%, 25g

Fmoc-(RS)-3-amino-3-(4-nitrophenyl)-propionic acid, 97%, 250mg

3-Cyclohexylpropionic acid, 95.0%, 25g

1-(2-Isopropylthiazol-4-yl)-N-methylmethanamine hydrochloride, 95.0%, 100g

HPLC-Säule NUCLEODUR®, C18 Gravity, 3 µm, 150x4,6 mm, 1 Stück

N-(3-Fluoro-4-methyl-8-oxo-5,6,7,8-tetrahydronaphthalen-1-yl)acetamide, 98%, 5g

Ethyl 3-Aminothieno[2,3-b]pyridine-2-carboxylate, 97.0%, 5g

Ethyl 4-pyrimidinecarboxylate, 95.0%, 25g

3-Amino-9-ethylcarbazole [for Biochemical Research]>90.0%(HPLC)(T)1g

3-(1,2-oxazinan-2-yl)propanoic acid hydrochloride, 95.0%, 25g

3-(4-Bromophenyl)propan-1-ol, 95.0%, 5g